3-(4-bromophenyl)-1H-pyrazole-4-carboxylic acid, 250mg

1-(1-(2-Methoxy-4-nitrophenyl)piperidin-4-yl)-4-methylpiperazine, 97%, 100mg

2-Chloro-4-phenylquinazoline, 95.0%, 25g

2-Amino-1H-benzo[d]imidazol-5-ol, 95.0%, 1g

(S)-4-(1-Aminoethyl)-2-methoxybenzoic acid hydrochloride, 95%, 250mg

1-Methyl-2-phenylcyclopropane, 10g

6-Bromo-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one, 97.0%, 1g

Formic acid D 95% solution in D2O, 98 atomic%D, 5 ml, glass packaging

(2E)-1-(2,4-dimethylphenyl)-3-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g

N-(4-piperidinylmethyl)acetamide hydrobromide, 95.0%, 50g

(3-((2,2,2-Trifluoroethoxy)methyl)phenyl)boronic acid, 98+%, 100mg

L-Proline Benzyl Ester Hydrochloride>98.0%(HPLC)(T)25g

N-Nitrosuccinimide>90.0%(GC)1g